JPMORGAN CHASE & CO - 30 Jun 2025 SCHEDULE 13G/A Report for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Symbol: RADX
Shares outstanding: 2,449,788,256 shares
Disclosed Ownership: 220,480,943 shares
Ownership: 9%
Form type: SCHEDULE 13G/A
Filing time: 16 Jul 2025, 09:34:25 UTC
Date of event: 30 Jun 2025
Previous filing: 11 Feb 2025
Next filing: 16 Jan 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	9%	220,480,943	220,480,943	0	Rachel Tsvaygoft	Vice President